Infectious Disease

Avacta to make a high performance Affimer research ELISA test available to support global research efforts to combat the coronavirus

Bespoke custom contract service offers rapid access to broad range of high-quality antigen panels for influenza A and B viruses

The biomarkers and technologies that make rapid, on-site diagnosis possible

Recent research describes how individualization with pharmacogenomics may improve the efficiency and safety of these therapies

Study in 38 Michigan hospitals shows need for faster in-hospital testing for coronavirus and other infections, which could reduce overuse of antibiotics

A new SARS-CoV-2 spike protein biosensor chip was successfully deployed for simultaneous measurements of IgG, IgA, and IgM using only 2 µl of serum per patient

Implications include clinical diagnostic test under development and targeted therapies

A key protein the virus uses to initiate infection does not operate as previously thought, researchers report